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School of Medicine Receptor occupancy by endogenous stimuli is ac-
La Jolla, California 92093-0636 companied by conformational changes that result in re-
ceptor activation, due tochanges either in the functional
properties of the receptors themselves or in the interac-
tion of the receptor molecule with transducer and ef-Worldwide concerns have emerged about a group of
fector systems. As shown in Figure 1A, one can imagineenvironmental agents (collectively termed endocrine
a receptor as existing in one of two states: active (Ra)disruptors) that may be producing adverse healtheffects
and inactive (Ri). This two-state system can be repre-in human beings and wildlife by mimicking or interfering
sented by three constants: the equilibrium dissociationwith the actions of endogenous hormones. (National
constants, KDa and KDi, for the Ra and Ri states of theScience and Technology Council Report ªThe Health
receptor, respectively, and an isomerization constant,and Ecological Effects of Endocrine Disrupting Chemi-
calsº). In response to a U. S. Congress mandate through
two 1996 laws, the Safe Drinking Water Act and the
Food Quality Protection Act, the Environmental Protec-
tion Agency (EPA) is developing screening and testing
guidelines to evaluate nearly 87,000 chemicals and mix-
tures for their possible effects on the endocrine system
(Chemical and Engineer News, February 9, 1998, pp.
7±8). This effort is part of an EPA-wide initiative to de-
velop science-intensive approaches for assessing health
risks of environmental agents.
A Receptor Biology Roundtable involving leading aca-
demic, industrial, and regulatory agency scientists and
organized by William Greenlee (University of Massachu-
setts Medical School) and Armen H. Tashjian, Jr. (Har-
vard School of Public Health) was held in December,
1997, in Wellesley, Massachusetts. The Receptor Biol-
ogy Roundtable was sponsored by the Research Foun-
dation for Health and Environmental Effects, the Office
for Research and the Department of Pharmacology and
Molecular Toxicology (University of Massachusetts Med-
ical Center), and the Department of Molecular and Cellu-
lar Toxicology (Harvard University School of Public
Health). The group gathered for the Roundtable re-
viewed the essential elements of receptor theory and
the rapidly expanding molecular insights concerning re-
ceptor mechanisms and signaling pathways in an effort
to define the knowledge base that should be incorpo-
rated in developing risk assessment approaches for en-
docrine disruptors.
Receptor Theory
Figure 1. A Model for Receptor-Mediated ResponseAs expressed at the turn of the century by Ehrlich, cor-
(A) The simplest two-state system can be described as a receptorpora non agunt nisi fixata, agents cannot act unless they
interconverting between two states, Ra (active) and Ri (inactive), thatbind. The cellular binding entity has been termed the
are in equilibrium Ra →← Ri. KDi and KDa are the equilibriumdissociation
receptor, a molecule that has the bifunctional properties constants for the inactive and active states, respectively. M is an
of both recognition and signal activation. Receptors act isomerization constant 5 Ra/Ri. More complex models exist but may
surpass theextant data relevant to risk assessment of environmentalvia diverse mechanisms, however, and a plethora of
toxins.signaling pathways orchestrate cellular regulation in re-
(B) Effects of drugs on the relative concentration of two hypotheticalsponse to extracellular cues, including agents endoge-
forms of a receptor, Ra (active) andRi (inactive), that are in equilibriumnous to organisms as well as those introduced from the
Ra →← Ri. The relative distribution of the receptor between these
environment. Despite the diversity and complexity of forms is differentially influenced by agonists (A), partial agonists
molecular mechanisms that translate receptor occu- (P), competitive antagonists (C), and negative antagonists (N), also
known as inverse agonists.pancy to response, receptor theory provides a means
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Figure 2. Schematic Diagram of the Diversity of Mechanisms for Control of Cell Function by Receptors for Endogenous Agents Acting via
the Cell Surface or in the Nucleus
Extant data are consistent with a model where endocrine disruptors act as agonists or antagonists at steroid receptors. (The figure shown
is modified from Ross, 1996.)
M, which describes the ratio of the receptors, Ri/Ra, that 1B). In theory, endocrine disruptors or other toxicologi-
cal agents could interact with receptors as agonists,are in the inactive versus active states.
partial agonists, antagonists, or negative antagonists.Agents that preferentially interact with the Ra state,
At the Receptor Roundtable, extant understandingsor elicit conformational changes converting the Ri to an
of how diverse cellular receptors elicit physiological re-Ra state, are referred to as agonists. Agonists vary in
sponses were reviewed, and are summarized below.their relative affinity for the Ra and Ri conformations,
Since risk assessment typically involves extrapolationsor states. A full agonist, like most endogenous agents,
to concentrations of environmentally available agentspreferentially interacts with Ra such that, at a saturating
(e.g., in ppm) that are unattainable experimentally, iden-concentrations, it drives the receptor population com-
tifying the interaction of an endocrine disruptor or xeno-pletely to the active state (cf. agent A in Figure 1B).
biotic mechanistically provides the opportunity to makeSome agonists have only a slightly greater affinity for
those extrapolations based on a quantitative framework.Ra than Ri and may elicit a diminished response even at
Consequently, the state of the art overview of receptorsaturating occupancy; these agents are referred to as
mechanisms and signal transduction pathways exploredpartial agonists (shown as P in Figure 1B). Agents that
at the Receptor Roundtable served as a prelude to dis-
bind with equal affinity to the Ri and Ra states but whose cussions of how these molecular details, considered in
occupancy of the receptor blocks agonist occupancy
the context of receptor theory, might inform public pol-
are called antagonists; such agents have no intrinsic icy for risk assessment.
ability to modify cellular functions, but effectively block, Signal Transduction
or competitively antagonize, agonist-elicited responses Figure 2 provides a schematic diagram of the diversity
(shown as C in Figure 1B). In contrast, agents exist (and by which extracellular cues regulate diverse cellular
often have profound therapeutic value) that preferen- functions, the overall process of which is referred to as
tially interact with the Ri state of the receptor; these signal transduction. Many neurotransmitters, for exam-
negative antagonists (or inverse agonists) as they are ple, interact with receptors that are themselves ion
called, suppress any ªbasal,º or agonist-independent, channels, as reviewed by Palmer Taylor (University of
effects of the receptor as well as block agonist occu- California, San Diego). Similarly, growth or differentia-
tion factors as well as cytokines interact with cell surfacepancy when agonists are present (shown as N in Figure
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receptors that are also the effector molecules, such as that exploit these tyrosine kinase cascades regulate pro-
tyrosine or serine/threonine kinases, reviewed by Roger cesses as diverse as growth, differentiation and apopto-
Davis (University of Massachusetts, Worcester) and sis. This functional diversity arises from the existence
Joan MassagueÂ (Memorial Sloan Kettering Institute), re- of three known MAP kinase pathways, dubbed erk, p38,
spectively. In many cases, however, the receptor mole- and JNK (JUN kinase), the latter two typically nonover-
cule is not also the effector. For the family of serpentine lapping pathways being preferentially activated by cellu-
receptors, agonist-activated receptors mediate these lar stressors, such as starvation, UV radiation, changes
effects by first coupling to GTP-binding proteins (G pro- in pO2, elevated temperature, and dramatic changes in
teins) that transduce the signal from the Ra state of osmolality of the cellular environment. Since all mem-
the receptor to a variety of effectors, including enzymes bers of the MAP kinase family are regulated by dual
and ion channels (reviewed from different perspectives phosphorylation on tyrosine and threonine, they repre-
by Martin Rodbell [National Institute of Environmental sent an important cellular mechanism for convergence
Health Sciences], Lee Limbird [Vanderbilt University, of information from tyrosine kinase receptors on the cell
Nashville TN], and Paul Insel [University of California, surface and regulatory Ser/Thr kinases in the cytoplasm.
San Diego]). Not all cellular regulation, however, is or- Activation of the JNK kinases specifically occurs in re-
chestrated by receptors at the cell surface; Jan-AÊ ke sponse to environmental stressors such as UV radiation
Gustafsson (Karolinska Institute, Huddinge, Sweden), and chemical toxins. Roger Davis summarized findings
Leonard Pinsky (McGill University, Montreal, Canada), on the role of JNK in neuronal cell death following gluta-
and Jack Gorski (University of Wisconsin, Madison, WI) mate excitotoxicity as well as anoxia. The amplification
described the interactions of gonadal steroids with es- in these signaling pathways precludes a straightforward
trogen and androgen receptors. It is thesesteroid recep- prediction of the extent of response that will be elicited
tors, in fact, that are the presumptive targets of endo- by a given receptor agonist, partial agonist, or inverse
crine disruptors and other environmental toxins, such agonist; furthermore, since environmental toxins need
as dioxin, as described by William Greenlee and Alan not necessarily act at the cell surface receptor but could
Poland (National Institute of Occupational Health and alter cellular response by interfering with, or mimicking,
Safety). activation of downstream molecules, it is difficult to cre-
Ligand-Gated Ion Channels ate a predictive correlation of the consequence of envi-
Palmer Taylor utilized the well-characterized nicotinic ace-
ronmental toxins on these tyrosine kinase cascades,
tylcholine receptor, which links nerve tomuscle commu-
despite their demonstrated role in cellular response to
nication at the neuromuscular junction, as the model for
environmental stressors.
understanding the regulatory paradigm of ligand-gated Receptor Serine/Threonine Kinases
ion channels. In this setting, both ligand recognition and
The transforming growth factor b (TGFb)±signaling path-
receptor activation are intrinsic to a single molecule, and
way, reviewed by Joan MassagueÂ , shows many para-one conformational change mediates the translocation
digmatic similarities to signaling through receptor tyro-of z5 3 104 ions, providing an immediate amplification
sine kinases, except that the catalytic activity inherent inof signal propagation either through ion translocation or
TGFb receptor heterodimers is a Ser/Thr kinase whosethe resulting membrane depolarization. For the nicotinic
substrates include the recently discovered family ofreceptor, two binding sites for acetylcholine, the native
SMAD proteins (reviewed in MassagueÂ , 1996). Threeagonist, exist on this pentameric molecule, and the re-
subunits exist for the TGFb receptor, designated as thesponse is positively cooperative. This cooperativity per-
type I, II, or III receptor subunits. Heterodimerization ofmits dramatic responses to small changes in agonists.
the type I with the type II receptor subunit constitutesHowever, if toxic agents or environmental pollutants
an active receptor. The role of the type III receptor,were to interact with ligand-gated ion channels in a
and its contribution to signaling, if it occurs, has notsimilar fashion, the cooperativity in ligand activation
been definitively established. TGFb, or activin, receptor-would approach a threshold phenomenon, thus preclud-
mediated phosphorylation of homodimeric forms of theing linear or direct extrapolation to concentrations suffi-
SMAD2 or -3 isoforms (or SMAD1, -5, or -9 isoforms byciently low to prevent a response.
the functionally homologous bone morphogenic peptideReceptor Tyrosine Kinases
receptor) results in a phosphorylation-dependent disso-Roger Davis reviewed the plethora of signaling cas-
ciation of the homodimeric complex and associationcades activated by the receptor tyrosine kinases (see
with a collaborating SMAD molecule, of which SMAD4Davis, 1995; Whitmarsh and Davis, 1996, for reviews)
is the only one known to date. The receptor-phosphory-The general paradigm in these pathways is that the
lated SMADs carry SMAD4 into the nucleus, where theyligand-binding molecule itself possesses tyrosine ki-
alter transcription by forming complexes with other DNA-nase activity, or associates with a non±receptor tyrosine
binding proteins. Antagonistic SMADs also exist, andkinase in a regulated manner, as occurs for cytokine re-
their association with receptor-phosphorylated SMADsceptors. Receptor homodimerization or cytokine recep-
prevents association with SMAD4 and productive nu-tor subunit association leads to activation of a tyrosine
clear regulation. SMAD-dependent pathways can alsokinase activity. The phosphorylated tyrosine substrates,
be inhibited by other signaling cascades, such as MAPoften including autophosphorylation of the endofacial
kinase pathways. Regulation in this combinatorial sig-domains of the receptors themselves, serve as recogni-
naling pathway can occur at the level of receptor bind-tion motifs for the binding of so-called SH2 domains in
ing, hetero-oligomerization among the TGFb I, II, or IIIother molecules, thus promoting the assembly of signal
isoforms, in the phosphorylation of SMADs and theirtransduction complexes that link surface receptor acti-
vation to changes in nuclear transcription. Receptors association with antagonistic SMADs or the SMAD4
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comediator of transcriptional regulation, or in modula- and inducing a conformational change that permits or
tion of these events by intervening regulatory pathways modifiespreexisting binding toDNA regulatory elements
activated by distinct cellular receptors, and all of these and modulation of transcription as part of a multiprotein
regulatory networks represent possible loci for modifi- transcriptional regulatory complex (Perlmann and Ev-
cation by environmental agents. ans, 1997). Jan-AÊ ke Gustaffson indicated that unap-
G Protein±Mediated Signaling via Cell preciated diversity in steroid signaling exists, as we are
Surface Receptors still discovering the molecular identity of new estrogen
Martin Rodbell, one of the first investigators to recognize receptors. For example, molecular cloning has revealed
the role of GTP in signal transduction and recipient of a new estrogen receptor, ERb, which is structurally ho-
the 1994 Nobel Prize (with Alfred G. Gilman), in recogni- mologous to its well-characterized ªsibling,º ERa, but
tion of his discovery of G proteins, described the diver- displays a unique tissue distribution and antagonistic
sity of regulatory paradigms now appreciated to influence response to estrogen binding. Thus, whereas 17b-estra-
G protein signaling. The Ra state of G protein±coupled diol binding to ERa leads to transcriptional activation
receptors (GPCRs) interacts with and activates the het- from an AP1 interaction site on DNA, binding to ERb
erotrimeric G protein. In turn, the GTP-liganded a sub- leads to transcriptional inhibition. The anti-estrogens
unit and temporarily dissociated bg subunits, serve as tamoxifen and raloxifene, defined as estrogen antago-
transducers, alone or in combination, of activating sig- nists based on their blockade of transcription via ERa,
nals to a variety of enzymes (including adenylyl cyclase, serve as potent transcriptional activators when bound
phospholipases A2, Cb, and D, MAP kinase) and ion to ERb (Paech et al., 1997). Consequently, responses
channels (including the receptor-operated K1 channel elicited by environmental estrogens will be determined
and voltage-sensitive Ca21 channels). The pleiotropism by the receptor, or more likely the receptors, with which
of signaling that can arise subsequent to activation of these agents can interact, as well as by the tissue distri-
GPCR results from the ability of these receptors to cou- bution of these receptors in males and females, and the
ple to multiple G proteins, the ability of G protein sub- cellular context of estrogen-responsive elements on the
units (a and bg dimers) to both carry signaling informa- DNA of target cells, as well as the expression of coacti-
tion, and the diversity of effectors that can be modulated vators and corepressors.
by the G protein subunits (Neer, 1995). Recently, a family Nuclear Receptors as Targets for Pollutants
of functionally, but not structurally, related regulatory As indicated by William Greenlee, endogenous nuclear
proteins, dubbed RGS molecules (Dohlman and Thorner, receptors that sense and respond to oxidant stress and
1997) has been described that can accelerate the turnoff environmental toxins also serve as transcription factors.
of G protein±mediated pathways. Thus, G protein±medi- These nuclear receptors are of special relevance to de-
ated signaling can be seen as a continuum of complexes veloping policy to assessthe risk of exposure to environ-
among ligands, receptors, G protein subunits, RGS and
mental toxins, as they have demonstrated roles as mod-
effector molecules whose coincident interactions regu-
ulators of the actions of environmental estrogens and
late cellular response. Facilitation or perturbation of these
dioxins.
complexes by environmental agents would thus alter
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or dioxin)the sensitivity or the extent of the biological response,
and structurally related environmental aromatic hydro-or both.
carbons, as well as dietary indole carbinols, bind andPaul Insel emphasized that human diseases which
activatea basichelix-loop-helix (bHLH) receptor protein,arise from mutations in G protein±coupled receptors or
dubbed AhR. In its ligand-bound form, AhR interactsthe G proteins themselves have been informative about
with a second bHLH protein, designated as ARNT for Ahimportant regulatory steps in GPCR pathways. An im-
receptor nuclear translocation, and the resultant AhR/portant lesson from these diseases appears to be the
ARNT heterodimer activates gene transcription by bind-impact of stoichiometry on stochastic activation of re-
ing to dioxin-responsive enhancer elements (reviewedceptor±G protein±effector pathways. As emphasized by
in Schmidt and Bradfield, 1996). ARNT also serves asLee Limbird, this stoichiometry of receptor:G proteins:
the heterodimerization partner for HIF-1a, a nuclear re-effectors is further controlled by microlocalization of
ceptor activated by hypoxia (Semenza, 1996), thus link-receptors, G proteins, and effectors to discrete surface
ing oxidant stress and dioxin signaling pathways throughdomains of target cells (Keefer et al., 1994; Neubig, 1994;
a common protein partner required for transcriptionalWozniak and Limbird, 1996). Modeling of the activation
activation of relevant target genes.of GPCRs and the resultant signaling pathways, which
The human androgen receptor, as indicated by Leo-relies on estimates of receptor and effector concentra-
nard Pinsky, plays a key regulatory role, not only in normaltions, is thus confounded by not knowing the density
sexual development, but also in the pathogenesis of pros-of molecular players in these presumptive signaling mi-
tate cancer. The observation that p,p9-DDE, the majorcrodomains when compared to their concentration esti-
metabolite of the estrogenic pesticide DDT, is a moremated experimentally for the entire cell or tissue. Simi-
potent antagonist at androgen receptors than it is anlarly, assessing the impact of environmental toxins on
agonist at estrogen receptors (Kelce et al., 1995), sug-particular GPCR-mediated responses also will require
gests that the reported estrogenicity of p,p9-DDE (Sotoinsights into the nature of the target tissue, including
et al., 1995) may reflect perturbations in the balance ofthe impact of signaling complex localization on the stoi-
modulation of androgen and estrogen receptors, andchiometry of receptors:G proteins:effectors.
identifies another issue that will need to be addressedReceptors as Transcription Factors
in developing and refining public policy relevant to riskThe steroids, including estrogen and androgen, mediate
assessment, namely predicting quantitatively the con-their pleiotropic functions by binding their cognate ste-
roid receptors, either in the cytoplasm or in the nucleus, sequence of functionally antagonistic, additive, or even
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synergistic effects of individual environmental toxins on tissue samples in various background populations (for
human beings or wildlife. a study carried out in St. Louis, Missouri, see Graham
Jack Gorski noted that the developmental toxicity ob- et al., 1986) showed that the levels of TCDD, the most
served in the offspring of diethylstilbestrol (DES)-treated potent and widely studied dioxin isomer, in human be-
mothers in the absence of discernable toxicity to the ings ranges from 5 to 10 ng/kg. To determine the amount
mothers themselves has led to the hypothesis that estro- of daily exposure that could lead to an accumulation
gen-dependent actions on growth and development are producing an undesired outcome (e.g., liver tumors) in
more sensitive than the estrogen-dependent regulation human beings over time, the relationship between expo-
of gene expression and physiological function in differ- sure, accumulation and response is evaluated in at least
entiated cells. For example, estrogen-dependent reg- two rodent species in chronic feeding studies.
ulation of cell growth and prolactin production in PR1 As noted by Alan Poland, the EPA has established
cells, a rat estrogen-responsive cellderived by estradiol- an ADI value for dioxin of 6 fg/kg/day using a linear
induced pituitary tumors, appears to occur with an EC50 multistage (LMS) extrapolation of liver tumor data from
of 10 fM, which is three orders of magnitude lower that a two-year rat study (Kociba et al., 1978). The LMS ex-
the EC50 for prolactin production and estradiol binding, trapolation to define cancer risk assumes that response
suggesting that a minute number of estrogen receptors to a potential carcinogen is linear over the entire expo-
need to be activated to elicit the growth response. Be- sure range; the ADI is based on an acceptable risk level
fore exploiting PR1 cells as an indicator of develop- of 1 3 1026. Additional assumptions in these extrapola-
mental toxicity, however, it will beessential to determine tions are that the risk for tumors given a particular expo-
rigorously whether or not these highly sensitive growth sure and fat depot accumulation is the same for human
responses are mediated by the same receptor that acti- beings as for the rodents, when the dose is defined as
vates prolactin production, but with a different degree amount of exposure/body surface area. In light of the
of amplification of the estradiol binding signal. At a mini- same animal data and extant human fat depot levels, the
mum, the profound sensitivity of the response to estra- Canadian Ministry of Environment (Environment Can-
diol in this model system argues for exercising caution ada) has established an ADI for dioxin of 10 pg/kg/day,
in the use of estrogen-dependent gene expression assays i.e., a value 1670 times higher than the ADI established
in the development of quantitative models for predicting by the EPA. Environment Canada's risk assessment ap-
the potential adverse outcomes of environmental es- proach uses different algorithms for extrapolating ani-
trogens. mal findings to the human population, including the as-
Epidemiology and Public Policy sertion that there exists a no-observable-untoward side
Currently, public policy concerning riskpotential derives effect level (NOEL) of 0.001 g/kg/day, based on the find-
from the assessment of both animal bioassays and epi- ings in rodents, and a calculated safety factor of 100 to
demiological data, followed by extrapolation of those
account for potential interspecies differences.
findings into recommendations for the general public Translating Receptor-Mediated Signaling Insights
and wildlife. However, sometimes the epidemiological
into Toxic Equivalency Recommendations
data are limited, and thus the extrapolations are exag-
How is it that limited tissue dosimetry data of potentiallygerated and the public policy recommendations prema-
toxic substances in human adipose tissue might beture. For example, as discussed by Ruth Allen (National
linked to experimental findings in rodents by mathemati-Cancer Institute), carcinogenicity of organochlorine com-
cal assumptions that give rise to widely discrepant pub-pounds such as the pesticide DDT (banned in 1972)
lic policy for two countries, the USA and Canada, whoseand polychlorinated biphenyl (PCB) mixtures (produced
inhabitants share comparable nutrition, manufacturingbetween 1929 and 1977) was suggested by the observed
(i.e., pollutant potential), and overall quality of life? Givencorrelation of an increase in the risk of breast cancer
all that is known about the mechanisms of action ofwith serum levels of DDE in a prospective study involving
endogenous substances via receptor-mediated signal-58 women in New York; a nonsignificant association of
ing pathways and the probable cellular loci where envi-breast cancer risk was noted with PCBs in the same
ronmental toxins like dioxin or endocrine disruptors act,study (Wolff et al., 1993). However, larger prospective
wouldn't it seem reasonable to propose that, in devel-studies of 150 cases of breast cancer in the San Fran-
oping new public policy, we should take the opportunitycisco Bay area (Krieger et al., 1994) and of 240 women
to incorporate these insights into our mathematical ex-with breast cancer (compared with 240 control women)
trapolations of acceptable exposures? Indeed, this queryin the Nurses' Health Study (Hunter et al., 1997) demon-
was the underlying premise for the gathering of the Re-strated no overall increase in breast cancer risk with
ceptor Roundtable at the close of 1997, and the reasonelevated serum levels of either DDE or of PCBs. This
for its joint funding by both the chemical industry andraises the dilemma of how to protect the public and the
academia.natural world around us while minimizing the financial
At the outset of this meeting summary, a simple modeland emotional costs of overreactive policy.
of receptor occupancy and activation was outlined thatTwo very different regulatory approaches have been
can describe, with some individualized modifications,used by agencies in the United States and Canada to
virtually all of the cellular signaling pathways defined inestablish acceptable daily intake (ADI) values for dioxin,
molecular detail to date. Receptor occupancy is rarelyan unwanted contaminant in certain commercial prod-
linearly related to response, as there typically is an am-ucts and in the incineration of wastes containing dioxin
plification of signals (cf. Figure 3): z105 ions moving perprecursors. The public perception of the human health
conformational change of a ligand-gated ion channel;risks to dioxin has been based in part on the extreme
multiple catalytic cycles of tyrosine or Ser/Thr kinasetoxic potency of this compound in certain animal spe-
cies and tumorigenicity in rodents. Analyses of adipose activity in activated growth and differentiation factor
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Figure 3. Agonist Interactions with Biological
Receptors
(A) In the simplest circumstance, agonist oc-
cupancy of the receptor obeys the law of
mass action, and the relationship between
agonist concentration (linear scale) and re-
sponse is reflected by a rectangular hyper-
bolic relationship.
(B) A plot of response versus log [agonist]
reveals a sigmoidal relationship between oc-
cupancy and response such that, in the absence of negative or positive cooperativity, 10% to 90% response occurs over approximately a
100-fold range of agonist concentration, ªcenteredº about the EC50 for agonist, the concentration of agonist that elicits a half-maximal response.
(C) Typically, signal amplification occurs between receptor occupancy, effector activation, and ultimate response, such that dose±response
curves (described at their midpoint by an EC50 value) often fall to the left of receptor occupancy profiles (defined by the KD of the receptor
for ligand).
receptors; catalytic activation of G proteins with varying defined in terms of [R0], [A], KDa, and KE by substituting
[AR] in this equation with [R0][A]/(KDa 1 [A]). Two impor-lifetimes of activated states by Gprotein±coupled recep-
tors, and multiple transcriptional initiation events per tant consequences evolve from Black and Leff's formu-
lation. First, the transducer function, i.e., those molecu-conformational change and DNA docking event of nu-
clear receptors that serve as transcription factors. None- lar events that link occupancy to response, must be
hyperbolic if the E/[A] relationship is hyperbolic, an ex-theless, a characteristic sigmoidal dose±response rela-
tionship can be demonstrated to be expected for all pectation that is not intuitive, but nonetheless argues
against linear extrapolations, whether they be under-receptor-mediated cellular events where the initial li-
gand-receptor interactions are described by mass ac- taken to predict physiological responses or to assess
risk to human beings secondary to environmental toxintion law (Black et al., 1985). In a model termed ªopera-
tional agonism,º Black and Leff (1983) developed a exposure. Second, the efficiency by which receptor oc-
cupancy is transduced to a biological effect can bequantitative description of the nonlinear relationship be-
tween occupancy and response. If an agonist, A, binds quantified by a descriptor, dubbed t (tau), which is de-
fined as [R0]/KE:to receptors in a bimolecular reaction driven by the rela-
tive concentrations of A and R and the AR complex (i.e.,
obeying mass action law), then: E 5
Emtn[A]n
(KDa 1 [A])n 1 tn[A]n
[AR] 5
[R0][A]
KDa 1 [A] It can be seen that t reflects the properties of the target
tissue, regardless of whether the tissue response is to
Where [R0] is total receptor concentration and KDa is the an endogenous agent, a drug, or an environmental toxin.
equilibrium dissociation constant, M, for the agonist A. The coefficient, n, reflects the complexity of the system;
This relationship takes the form of a rectangular hy- when the system operates as a series of simple bimolec-
perbola, y 5 mx/(a 1 b), the familiar shape of ligand± ular reactions without cooperativity, for example, the
receptor occupancy data when the amount of receptor value of n 5 1. However, the operational agonism model
binding achieved is plotted as a function of increases also provides descriptors for experimental E/[A] curves
in ligand concentration on a linear scale (Figure 3A). that are steeper (positively cooperative; n . 1) than
When positively cooperative phenomena occur upon predicted for a simple rectangular hyperbola, such as
receptor occupancy, as is characteristic of the nicotinic those linking receptor occupancy to ion translocation
cholinergic receptor system described by PalmerTaylor, through the nicotinic acetylcholine receptor. Negatively
then the exponent describing the [AR] complex is not cooperative phenomena are infrequently seen in biologi-
1.0, but is greater than 1.0, and is determined by the cal systems, but would be described in this equation
free energies describing the conformational changes by n , 1. The t value is influenced not only by the
that link the cooperative binding phenomena, not by the concentration of R in the tissue, including varying R
number of binding sites for ligand. When cooperativity densities within a tissue due to localization of signaling
occurs, this complexity is then propagated onto the complexes into discrete microenvironments if this oc-
subsequent receptor-mediated signaling events. curs, but also by the consequences of ligand±receptor
To describe the link between occupancy and re- interaction, i.e., the potency of an agonist in eliciting a
sponse mathematically, Black and Leff posited that the response due both to receptor affinity for the agonist
concentration of the agonist-receptor complex, [AR], and receptor efficiency in translating agonistoccupancy
is related to the biological effect measured, E, by a to response.
rectangular hyperbolic function of [AR]: This theoretical framework suggested to those partici-
pating in the Receptor Roundtable that it might be useful
E 5
Em[AR]
KE 1 [AR]
to obtain, as a test of the validity of using operational
agonism for quantitating the risk potential of particular
environmental or other pollutants, the t values for theHere, Em is the maximal response, E is the effect elicited
at a given receptor occupancy, and KE is the concentra- effects of environmental toxins, such as endocrine dis-
ruptors, on different physiological responses. The ttion of [AR] that elicits a half maximal effect. E can be
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2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol. Appl.value for responses in the presence of a particular toxin
Pharmacol. 46, 279±303.would be compared for multiple target tissues evaluated
Krieger, N., Wolff, M.S., Hiatt, R.A., Rivera, M., Vogelman, J., andin more than one animal model system that serves as
Orentreich, N. (1994). Breast cancer and serum organochlorines: aa predictor for responses in human beings. If these t
prospective study among white, black, and Asian women. J. Natl.
values are reasonably constant for a particular environ- Cancer Inst. 86, 589±599.
mental toxin in all of these experimental settings, then MassagueÂ , J. (1996). TGFb signaling: receptors, transducers, and
it would seem reasonable to propose that extrapolation Mad proteins. Cell 85, 947±950.
of the concentration of toxin exposure to predicted ad- Neer, E.J. (1995). HeterotrimericG proteins:organizers of transmem-
verse effects could be reasonably related to the equa- brane signals. Cell 80, 249±257.
tions outlined above. Such an approach would provide Neubig, R.R. (1994). Membrane organization in G-protein mecha-
an opportunity to develop quantitative descriptors in nisms. FASEB J. 8, 27618±27624.
risk assessment that reflect the insights derived both Paech, K., Webb, P., Kuiper, G.G., Nilsson, S., Gustafsson, J., Kush-
ner, P.J., and Scanlan, T.S. (1997). Differential ligand activation offrom receptor theory and from the accelerating clarifica-
estrogen receptors ERa and ERb at AP1 sites. Science 277, 1508±tion of the detailed mechanisms for receptor-mediated
1510.signal transduction.
Perlmann, T., and Evans, R.M. (1997). Nuclear receptors in Sicily:Summary
all in the famiglia. Cell 90, 391±397.The Receptor Roundtable provided a timely opportunity
Ross, E.M. (1996). Pharmacodynamics: mechanisms of drug actionfor evaluating how risk might better be assessed for envi-
and the relationship between drug concentration and effect. In The
ronmental toxins, particularly those for which themolec- Pharmacological Basis of Therapeutics, Goodman and Gilman, eds.
ular basis for their adverse effects is known. The impor- New York, N.Y.: McGraw-Hill), chapter 2.
tance of incorporating receptor theory, which evolved Schmidt, J.V., and Bradfield, C.A. (1996). Ah receptor signaling path-
to describe experimentally observed dose±response ways. Annu. Rev. Cell Dev. Biol. 12, 55±89.
curves, and the emerging details about receptor signal- Semenza, G.L. (1996). Transcriptional regulation by hypoxia-induc-
ible factor I. Molecular mechanisms of oxygen homeostasis. Trendsing pathways into the algorithms that link toxic expo-
Cardiovasc. Med. 6, 151±157.sure, tissue dosimetry, and risk assessment cannot be
Soto, A.M., Sonnenschein, C., Chung, K.L., Fernandez, M.F., Olea,underestimated, particularly given the U. S. Congress
N., and Serrano, F.O. (1995). The E-SCREEN assay as a tool tomandate, through the Food Quality Protection Act and
identify estrogens: an update on estrogenic environmental pollut-the Safe Drinking Water Act, to develop guidelines for
ants. Environ. Health Perspect. 103, 113±122.
evaluating nearly 87,000 chemicals and mixtures for
Whitmarsh, A.J., and Davis, R.J. (1996). Transcription factor AP-1their possible effects on the endocrine system for the regulation by mitogen-activated protein kinase signal transduction
purpose of informing public policy. Those participating pathways. J. Mol. Med. 74, 589±607.
in the Receptor Roundtable conference were optimistic Wolff, M.S., Toniolo, P.G., Lee, E.W., Rivera, M., and Dubin, N. (1993).
that extant insights into the mechanisms by which re- Blood levels of organochlorine residues and risk of breast cancer.
J. Natl. Cancer Inst. 85, 648±652.ceptor occupancy is translated into biological response,
and the available mathematical algorithms which de- Wozniak, M., and Limbird, L. (1996). The three a2-adrenergic recep-
tor subtypes achieve basolateral localization in Madin-Darby caninescribe these mechanisms, will indeed reveal improved
kidney II cells via different targeting mechanisms. J. Biol. Chem.and science-driven policy determinants.
271, 5017±5024.
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